1.
Mehboob Z, Raza H, Riaz M, Habiba UE. Clinical Outcomes of CRISPR-Cas9 Mediated Gene Editing in Patients with Sickle Cell Disease A Biotechnology-Based Therapeutic Approach. IRABCS [Internet]. 2025 Jul. 10 [cited 2025 Jul. 12];3(1). Available from: https://irjpl.org/irabcs/article/view/126